AGC Pharma Chemicals continues to advance its commitment to sustainable innovation with the development of a next-generation API/HPAPI manufacturing facility in Barcelona, inaugurated in September 2025. This project represents a step change in how sustainability is integrated into pharmaceutical infrastructure—moving from a complementary feature to a core design principle.
Sustainability as a Core Design Principle
Unlike traditional approaches, this facility was conceived from the outset with sustainability at its core. The project was guided by three fundamental objectives: reducing carbon emissions, optimizing resource efficiency, and integrating renewable energy into pharmaceutical manufacturing operations.
These principles were translated into a comprehensive set of measures embedded directly into the plant’s architecture and operational concept. The facility integrates renewable energy technologies such as façade-integrated photovoltaics and solar thermal systems, alongside energy recovery through steam condensate reuse and water stewardship strategies based on reuse principles.
In parallel, the design incorporates resource-efficient utilities, including optimized nitrogen blanketing systems, energy-efficient compressed air solutions, and the use of low-global-warming-potential refrigerants.
Importantly, these sustainability-driven measures are fully aligned with advanced manufacturing requirements. The facility combines high-containment technologies, closed material handling systems, and flexible processing capabilities, ensuring that environmental performance is achieved without compromising safety, quality, or operational excellence.
This “sustainability by design” approach positions the site as a benchmark for future-ready pharmaceutical manufacturing.
Addressing Industry Challenges
Pharmaceutical manufacturing—particularly highly potent API (HPAPI) production—is inherently complex and resource-intensive. It requires strict containment, energy-intensive environmental controls, and advanced utility systems to ensure safety and compliance.
The key challenge addressed in this project was how to minimize environmental impact while maintaining the highest standards of technical performance and regulatory compliance.
AGC Pharma Chemicals tackled this by embedding sustainability directly into the engineering and infrastructure of the facility, rather than applying it as a retrofit. This integrated approach allows environmental considerations to coexist seamlessly with technical requirements.
Solutions such as renewable energy integration, energy recovery systems, water reuse strategies, and optimized utilities were implemented alongside advanced containment systems, cleanroom environments, and automated process controls. This ensures the facility delivers both operational excellence and reduced environmental impact.
Delivering Measurable Environmental Impact
The facility’s sustainable design translates into clear, quantifiable environmental improvements, combining renewable energy, energy efficiency and responsible water use:
- Solar thermal for sanitary hot water: Covers approximately 60% of annual thermal demand for this use, delivering an expected natural gas saving of 38,129 kWh/year and an estimated reduction of 7,011 kg CO₂/year.
- Façade-integrated photovoltaics: 77 kWp installed capacity, generating up to 72,000 kWh/year of renewable electricity to help power the production plant and reduce reliance on grid electricity.
- Steam condensate recovery: Reuses thermal energy for both manufacturing processes and facility climate control. Under full production conditions, it is expected to reduce annual natural gas consumption by 1,428,000 kWh/year and lower the carbon footprint by 257,040 kg CO₂/year.
- Water reuse: Greywater from showers and washbasins is reused for irrigation, avoiding the consumption of approximately 240 m³ of fresh water per year.
All estimated values are based on the plant operating under maximum performance and full capacity conditions.
Together, these measures demonstrate how a high-containment pharmaceutical facility can achieve substantial reductions in fossil energy use, carbon emissions and water demand, without compromising operational requirements.
Setting a Benchmark for the Industry
This initiative provides a clear example of how sustainability can be fully integrated into highly specialized pharmaceutical environments without compromising technical performance.
By combining renewable energy, energy recovery, water stewardship and resource-efficient utilities with high-containment manufacturing technologies, AGC Pharma Chemicals sets a new standard for the design of next-generation API/HPAPI facilities.
The project also supports long-term adaptability through a future-ready concept, including plug-and-play expansion capabilities and reserved space for additional technologies. This reinforces a key message for the industry: the pharmaceutical plants of the future must be both environmentally responsible and operationally adaptable and these objectives can be achieved simultaneously through integrated design.
